Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Performer
6380.0000
19.50
(
0.31
%)
NSE
Dec 31, 2025
14:44 PM
28.76% Gain from 52W Low
Volume:
187.6K
High vol. this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
09 Nov 2022
6380.00
0.31%
Divi's Labs (HOLD): Disappointing quarter
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3450
Target
BOB Capital Markets Ltd.
Q2 revenue fell 7% YoY to Rs 18.5bn, weighed down by a decline in custom synthesis business
Divi's Laboratories Ltd. is trading
above its 200 day SMA
of 6300.1
More from Divi's Laboratories Ltd.
Recommended
Market trades higher, Solar Industries bags Rs 1,746 crore explosives order
Trendlyne Marketwatch |
31 Dec 2025, 02:58PM
IPO activity is high on listings, but low on subscriptions
|
29 Dec 2025, 05:02PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022